• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Regenesis Biomedical

edit

Regenesis Biomedical, Inc., a medical technology company, focuses on developing and marketing noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery. Its customers include health care facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and wound care clinics. Regenesis Biomedical was founded in 1996 and is headquartered in Scottsdale, Arizona.

Recent Milestones

edit

• 
  Regenesis Biomedical received $5.3M in Series C funding. (6/6/11)
  Posted 6/6/11 at 5:43pm via finsmes.com
• 
  Regenesis Biomedical added Dennis Genge as VP Finance.
  Posted 6/6/11 at 5:43pm
• 
  Regenesis Biomedical added Virginia S. Rybski as President & CEO.
  Posted 6/6/11 at 5:43pm
• 
  Regenesis Biomedical added Scott Brooks as Chief Executive Officer.
  Posted 5/15/13 at 12:34am

Videos

Screenshots

edit

Sources

1. Regenesis Biomedical Completes $5.3M Series C Financing (finsmes.com) [edit]